Funding Rounds
Synendos Therapeutics

Synendos Therapeutics Series A (2020, $21M)

Synendos Therapeutics

Small molecules developed for treating anxiety and stress-related disorders.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →